Epilepsy, a chronic seizure disorder requiring long term health care contact, is one of the most non-infectious neurological disease in developing countries with serious physical, psychological, social and economic consequences for affected persons, families and society in general [1–3]. It affects about 50 million people worldwide with majority living in developing countries like Nigeria that has a prevalence ranges from 5.3 to 37 per one thousand persons [3,4]. The burden of epilepsy can be overwhelming for many individuals and their families, and can severely affect the quality of life of its sufferers [2,5–8].
15
NOV
NOV
0